Review



mntbap  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Santa Cruz Biotechnology mntbap
    Effect of <t>MnTBAP</t> cotreatment on the viability <t>of</t> <t>cisplatin-treated</t> UB/OC-1 cells. A) Dose-dependent cytotoxicity in UB/OC-1 cells after cisplatin treatment. B) Cell viability assay of UB/OC-1 cells after treatment with cisplatin, MnTBAP+Cisplatin, and MnTBAP alone indicates that the cisplatin-mediated cell death was attenuated with MnTBAP cotreatment Results are expressed as mean ± standard deviation, n = 7. ## p < 0.01 vs cisplatin.
    Mntbap, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 18 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mntbap/product/Santa Cruz Biotechnology
    Average 93 stars, based on 18 article reviews
    mntbap - by Bioz Stars, 2026-02
    93/100 stars

    Images

    1) Product Images from "MnTBAP, a peroxynitrite scavenger, attenuates cisplatin-induced apoptosis and cytotoxicity in organ of Corti cells"

    Article Title: MnTBAP, a peroxynitrite scavenger, attenuates cisplatin-induced apoptosis and cytotoxicity in organ of Corti cells

    Journal: Toxicology Reports

    doi: 10.1016/j.toxrep.2025.101967

    Effect of MnTBAP cotreatment on the viability of cisplatin-treated UB/OC-1 cells. A) Dose-dependent cytotoxicity in UB/OC-1 cells after cisplatin treatment. B) Cell viability assay of UB/OC-1 cells after treatment with cisplatin, MnTBAP+Cisplatin, and MnTBAP alone indicates that the cisplatin-mediated cell death was attenuated with MnTBAP cotreatment Results are expressed as mean ± standard deviation, n = 7. ## p < 0.01 vs cisplatin.
    Figure Legend Snippet: Effect of MnTBAP cotreatment on the viability of cisplatin-treated UB/OC-1 cells. A) Dose-dependent cytotoxicity in UB/OC-1 cells after cisplatin treatment. B) Cell viability assay of UB/OC-1 cells after treatment with cisplatin, MnTBAP+Cisplatin, and MnTBAP alone indicates that the cisplatin-mediated cell death was attenuated with MnTBAP cotreatment Results are expressed as mean ± standard deviation, n = 7. ## p < 0.01 vs cisplatin.

    Techniques Used: Viability Assay, Standard Deviation

    Effect of MnTBAP cotreatment on cisplatin-induced nitrative stress. A) Immunocytochemistry analysis with anti-nitrotyrosine was used to assess the nitrative stress in UB/OC-1 cells. Magenta staining indicates immunoreactivity to anti-nitrotyrosine while blue indicates nuclear staining with DAPI. B) Quantification of the immunostaining suggested that the level of 3-NT expression increased significantly with cisplatin treatment which was attenuated by MnTBAP cotreatment. The results are expressed as mean ± standard error, n = 6, ****p < 0.0001 vs control, #### p < 0.0001 vs cisplatin, scale bar = 20 µm.
    Figure Legend Snippet: Effect of MnTBAP cotreatment on cisplatin-induced nitrative stress. A) Immunocytochemistry analysis with anti-nitrotyrosine was used to assess the nitrative stress in UB/OC-1 cells. Magenta staining indicates immunoreactivity to anti-nitrotyrosine while blue indicates nuclear staining with DAPI. B) Quantification of the immunostaining suggested that the level of 3-NT expression increased significantly with cisplatin treatment which was attenuated by MnTBAP cotreatment. The results are expressed as mean ± standard error, n = 6, ****p < 0.0001 vs control, #### p < 0.0001 vs cisplatin, scale bar = 20 µm.

    Techniques Used: Immunocytochemistry, Staining, Immunostaining, Expressing, Control

    Effect of MnTBAP cotreatment on cisplatin-induced changes in the expression levels of apoptotic genes. A) Heat map depicts differentially expressed apoptotic genes in UB/OC-1 cells. The expression levels of genes in each treatment group were normalized with control. B) Cisplatin treatment induced the upregulation of many pro-apoptotic genes, while MnTBAP cotreatment attenuated their expression. MnTBAP cotreatment also upregulated the expression of anti-apoptotic genes. Results expressed as mean ± standard deviation, # p < 0.05, ## p < 0.01, n = 4.
    Figure Legend Snippet: Effect of MnTBAP cotreatment on cisplatin-induced changes in the expression levels of apoptotic genes. A) Heat map depicts differentially expressed apoptotic genes in UB/OC-1 cells. The expression levels of genes in each treatment group were normalized with control. B) Cisplatin treatment induced the upregulation of many pro-apoptotic genes, while MnTBAP cotreatment attenuated their expression. MnTBAP cotreatment also upregulated the expression of anti-apoptotic genes. Results expressed as mean ± standard deviation, # p < 0.05, ## p < 0.01, n = 4.

    Techniques Used: Expressing, Control, Standard Deviation

    Effect of MnTBAP cotreatment on cisplatin-induced changes in the expression levels of activated Caspase-3. A) Immunocytochemistry analysis of UB/OC-1 cell lines with anti-caspase-3 was used to assess apoptosis. Orange staining indicates immunoreactivity to anti-Caspase-3 while blue indicates nuclear staining with DAPI. B) Quantification of the staining intensity suggested that the level of activated Caspase-3 expression increased significantly with cisplatin treatment which was attenuated by MnTBAP cotreatment. The results are expressed as mean ± standard error, n = 6, ****p < 0.0001 vs control, #### p < 0.0001 vs cisplatin, scale bar = 20 µm.
    Figure Legend Snippet: Effect of MnTBAP cotreatment on cisplatin-induced changes in the expression levels of activated Caspase-3. A) Immunocytochemistry analysis of UB/OC-1 cell lines with anti-caspase-3 was used to assess apoptosis. Orange staining indicates immunoreactivity to anti-Caspase-3 while blue indicates nuclear staining with DAPI. B) Quantification of the staining intensity suggested that the level of activated Caspase-3 expression increased significantly with cisplatin treatment which was attenuated by MnTBAP cotreatment. The results are expressed as mean ± standard error, n = 6, ****p < 0.0001 vs control, #### p < 0.0001 vs cisplatin, scale bar = 20 µm.

    Techniques Used: Expressing, Immunocytochemistry, Staining, Control

    Effect of MnTBAP cotreatment on cisplatin-induced decrease in LMO4 levels. A) Immunoblot analysis with anti-LMO4 was used to assess LMO4 protein levels in UB/OC-1 cells. Actin was used for normalization. B) Quantification of the bands indicated that cisplatin treatment reduced LMO4 protein levels, while cotreatment with MnTBAP attenuated the cisplatin-mediated decrease in LMO4 levels. The results are expressed as mean ± standard error, n = 4, **p < 0.01 vs control, #### p < 0.01 vs cisplatin.
    Figure Legend Snippet: Effect of MnTBAP cotreatment on cisplatin-induced decrease in LMO4 levels. A) Immunoblot analysis with anti-LMO4 was used to assess LMO4 protein levels in UB/OC-1 cells. Actin was used for normalization. B) Quantification of the bands indicated that cisplatin treatment reduced LMO4 protein levels, while cotreatment with MnTBAP attenuated the cisplatin-mediated decrease in LMO4 levels. The results are expressed as mean ± standard error, n = 4, **p < 0.01 vs control, #### p < 0.01 vs cisplatin.

    Techniques Used: Western Blot, Control



    Similar Products

    99
    ATCC mntbap in dmso
    Mntbap In Dmso, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mntbap in dmso/product/ATCC
    Average 99 stars, based on 1 article reviews
    mntbap in dmso - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    93
    MedChemExpress mntbap
    SOD2 supplementation alleviates glomerulosclerosis and inhibits the vascular endothelial cells inflammation response. A) Masson's trichrome staining in different groups ( n = 8–9, Scale bar, 50 μm). B, C) Fibrotic area of glomerulus (B) and tubules (C) statistics of Masson's trichrome staining in different groups ( n = 8–9). D) PAS staining in different groups ( n = 8–9, Scale bar, 50 μm). E) Systolic blood pressure in different groups detected by tail-cuff ( n = 8–10). F) ELISA of urinary microalbumin in different groups ( n = 8–10). G) Analysis of Cr in different groups ( n = 8–9). H) Relative fluorescence intensity statistics of IF staining of Fibronectin ( n = 5). I) IF staining of Fibronectin in different groups ( n = 5, Scale bar, 20 μm). J, K) Western blot of Fibronectin in different groups. GAPDH was used as a control ( n = 4). Dot plots represent quantitative densitometric data from Western blot. L) IHC staining of F4/80 in different groups ( n = 5, Scale bar, 50 μm). M) IHC semi-quantitative IOD analysis of F4/80 ( n = 5). N, O) Western blot of CD31, VCAM-1, and ICAM-1 in immortalized <t>HAECs</t> <t>transfected</t> with shRNA of LONP1 and treated with <t>MnTBAP.</t> β-Actin was used as a control ( n = 3). Dot plots represent quantitative densitometric data from Western blot. P, Q) Western blot of CD31, VCAM-1, and ICAM-1 in MAECs transfected with shRNA of LONP1 and treated with MnTBAP. GAPDH was used as a control of CD31, β-Actin was used as a control of VCAM-1 and ICAM-1 ( n = 3). Dot plots represent quantitative densitometric data from Western blot. R, S) The IL-6 (R) and TNF-α (S) levels of cell medium in MAECs transfected with shRNA of LONP1 and treated with MnTBAP were detected by ELISA ( n = 3). T, U) Western blot of CD31, VCAM-1, and ICAM-1 in immortalized HAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid. β-Actin was used as a control ( n = 3). Dot plots represent quantitative densitometric data from Western blot. V, W) Western blot of CD31, VCAM-1, and ICAM-1 in MAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid. GAPDH was used as a control of CD31, β-Actin was used as a control of VCAM-1 and ICAM-1 ( n = 3). Dot plots represent quantitative densitometric data from Western blot. X, Y) The IL-6 (X) and TNF-α (Y) levels of cell medium in MAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid were detected by ELISA ( n = 3). IOD, Integral Optical Density.
    Mntbap, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mntbap/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    mntbap - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress hetero cko 5 6nx mntbap group
    SOD2 supplementation alleviates glomerulosclerosis and inhibits the vascular endothelial cells inflammation response. A) Masson's trichrome staining in different groups ( n = 8–9, Scale bar, 50 μm). B, C) Fibrotic area of glomerulus (B) and tubules (C) statistics of Masson's trichrome staining in different groups ( n = 8–9). D) PAS staining in different groups ( n = 8–9, Scale bar, 50 μm). E) Systolic blood pressure in different groups detected by tail-cuff ( n = 8–10). F) ELISA of urinary microalbumin in different groups ( n = 8–10). G) Analysis of Cr in different groups ( n = 8–9). H) Relative fluorescence intensity statistics of IF staining of Fibronectin ( n = 5). I) IF staining of Fibronectin in different groups ( n = 5, Scale bar, 20 μm). J, K) Western blot of Fibronectin in different groups. GAPDH was used as a control ( n = 4). Dot plots represent quantitative densitometric data from Western blot. L) IHC staining of F4/80 in different groups ( n = 5, Scale bar, 50 μm). M) IHC semi-quantitative IOD analysis of F4/80 ( n = 5). N, O) Western blot of CD31, VCAM-1, and ICAM-1 in immortalized <t>HAECs</t> <t>transfected</t> with shRNA of LONP1 and treated with <t>MnTBAP.</t> β-Actin was used as a control ( n = 3). Dot plots represent quantitative densitometric data from Western blot. P, Q) Western blot of CD31, VCAM-1, and ICAM-1 in MAECs transfected with shRNA of LONP1 and treated with MnTBAP. GAPDH was used as a control of CD31, β-Actin was used as a control of VCAM-1 and ICAM-1 ( n = 3). Dot plots represent quantitative densitometric data from Western blot. R, S) The IL-6 (R) and TNF-α (S) levels of cell medium in MAECs transfected with shRNA of LONP1 and treated with MnTBAP were detected by ELISA ( n = 3). T, U) Western blot of CD31, VCAM-1, and ICAM-1 in immortalized HAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid. β-Actin was used as a control ( n = 3). Dot plots represent quantitative densitometric data from Western blot. V, W) Western blot of CD31, VCAM-1, and ICAM-1 in MAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid. GAPDH was used as a control of CD31, β-Actin was used as a control of VCAM-1 and ICAM-1 ( n = 3). Dot plots represent quantitative densitometric data from Western blot. X, Y) The IL-6 (X) and TNF-α (Y) levels of cell medium in MAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid were detected by ELISA ( n = 3). IOD, Integral Optical Density.
    Hetero Cko 5 6nx Mntbap Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hetero cko 5 6nx mntbap group/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    hetero cko 5 6nx mntbap group - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Millipore mntbap code 475870
    SOD2 supplementation alleviates glomerulosclerosis and inhibits the vascular endothelial cells inflammation response. A) Masson's trichrome staining in different groups ( n = 8–9, Scale bar, 50 μm). B, C) Fibrotic area of glomerulus (B) and tubules (C) statistics of Masson's trichrome staining in different groups ( n = 8–9). D) PAS staining in different groups ( n = 8–9, Scale bar, 50 μm). E) Systolic blood pressure in different groups detected by tail-cuff ( n = 8–10). F) ELISA of urinary microalbumin in different groups ( n = 8–10). G) Analysis of Cr in different groups ( n = 8–9). H) Relative fluorescence intensity statistics of IF staining of Fibronectin ( n = 5). I) IF staining of Fibronectin in different groups ( n = 5, Scale bar, 20 μm). J, K) Western blot of Fibronectin in different groups. GAPDH was used as a control ( n = 4). Dot plots represent quantitative densitometric data from Western blot. L) IHC staining of F4/80 in different groups ( n = 5, Scale bar, 50 μm). M) IHC semi-quantitative IOD analysis of F4/80 ( n = 5). N, O) Western blot of CD31, VCAM-1, and ICAM-1 in immortalized <t>HAECs</t> <t>transfected</t> with shRNA of LONP1 and treated with <t>MnTBAP.</t> β-Actin was used as a control ( n = 3). Dot plots represent quantitative densitometric data from Western blot. P, Q) Western blot of CD31, VCAM-1, and ICAM-1 in MAECs transfected with shRNA of LONP1 and treated with MnTBAP. GAPDH was used as a control of CD31, β-Actin was used as a control of VCAM-1 and ICAM-1 ( n = 3). Dot plots represent quantitative densitometric data from Western blot. R, S) The IL-6 (R) and TNF-α (S) levels of cell medium in MAECs transfected with shRNA of LONP1 and treated with MnTBAP were detected by ELISA ( n = 3). T, U) Western blot of CD31, VCAM-1, and ICAM-1 in immortalized HAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid. β-Actin was used as a control ( n = 3). Dot plots represent quantitative densitometric data from Western blot. V, W) Western blot of CD31, VCAM-1, and ICAM-1 in MAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid. GAPDH was used as a control of CD31, β-Actin was used as a control of VCAM-1 and ICAM-1 ( n = 3). Dot plots represent quantitative densitometric data from Western blot. X, Y) The IL-6 (X) and TNF-α (Y) levels of cell medium in MAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid were detected by ELISA ( n = 3). IOD, Integral Optical Density.
    Mntbap Code 475870, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mntbap code 475870/product/Millipore
    Average 90 stars, based on 1 article reviews
    mntbap code 475870 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology mntbap
    Effect of <t>MnTBAP</t> cotreatment on the viability <t>of</t> <t>cisplatin-treated</t> UB/OC-1 cells. A) Dose-dependent cytotoxicity in UB/OC-1 cells after cisplatin treatment. B) Cell viability assay of UB/OC-1 cells after treatment with cisplatin, MnTBAP+Cisplatin, and MnTBAP alone indicates that the cisplatin-mediated cell death was attenuated with MnTBAP cotreatment Results are expressed as mean ± standard deviation, n = 7. ## p < 0.01 vs cisplatin.
    Mntbap, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mntbap/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    mntbap - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology mntbap sc-221954a
    Effect of <t>MnTBAP</t> cotreatment on the viability <t>of</t> <t>cisplatin-treated</t> UB/OC-1 cells. A) Dose-dependent cytotoxicity in UB/OC-1 cells after cisplatin treatment. B) Cell viability assay of UB/OC-1 cells after treatment with cisplatin, MnTBAP+Cisplatin, and MnTBAP alone indicates that the cisplatin-mediated cell death was attenuated with MnTBAP cotreatment Results are expressed as mean ± standard deviation, n = 7. ## p < 0.01 vs cisplatin.
    Mntbap Sc 221954a, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mntbap sc-221954a/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    mntbap sc-221954a - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    SOD2 supplementation alleviates glomerulosclerosis and inhibits the vascular endothelial cells inflammation response. A) Masson's trichrome staining in different groups ( n = 8–9, Scale bar, 50 μm). B, C) Fibrotic area of glomerulus (B) and tubules (C) statistics of Masson's trichrome staining in different groups ( n = 8–9). D) PAS staining in different groups ( n = 8–9, Scale bar, 50 μm). E) Systolic blood pressure in different groups detected by tail-cuff ( n = 8–10). F) ELISA of urinary microalbumin in different groups ( n = 8–10). G) Analysis of Cr in different groups ( n = 8–9). H) Relative fluorescence intensity statistics of IF staining of Fibronectin ( n = 5). I) IF staining of Fibronectin in different groups ( n = 5, Scale bar, 20 μm). J, K) Western blot of Fibronectin in different groups. GAPDH was used as a control ( n = 4). Dot plots represent quantitative densitometric data from Western blot. L) IHC staining of F4/80 in different groups ( n = 5, Scale bar, 50 μm). M) IHC semi-quantitative IOD analysis of F4/80 ( n = 5). N, O) Western blot of CD31, VCAM-1, and ICAM-1 in immortalized HAECs transfected with shRNA of LONP1 and treated with MnTBAP. β-Actin was used as a control ( n = 3). Dot plots represent quantitative densitometric data from Western blot. P, Q) Western blot of CD31, VCAM-1, and ICAM-1 in MAECs transfected with shRNA of LONP1 and treated with MnTBAP. GAPDH was used as a control of CD31, β-Actin was used as a control of VCAM-1 and ICAM-1 ( n = 3). Dot plots represent quantitative densitometric data from Western blot. R, S) The IL-6 (R) and TNF-α (S) levels of cell medium in MAECs transfected with shRNA of LONP1 and treated with MnTBAP were detected by ELISA ( n = 3). T, U) Western blot of CD31, VCAM-1, and ICAM-1 in immortalized HAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid. β-Actin was used as a control ( n = 3). Dot plots represent quantitative densitometric data from Western blot. V, W) Western blot of CD31, VCAM-1, and ICAM-1 in MAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid. GAPDH was used as a control of CD31, β-Actin was used as a control of VCAM-1 and ICAM-1 ( n = 3). Dot plots represent quantitative densitometric data from Western blot. X, Y) The IL-6 (X) and TNF-α (Y) levels of cell medium in MAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid were detected by ELISA ( n = 3). IOD, Integral Optical Density.

    Journal: Redox Biology

    Article Title: Endothelial Lon protease 1 facilitates the redox balance to prevent glomerulosclerosis by acting on superoxide dismutase 2 ubiquitination

    doi: 10.1016/j.redox.2025.103929

    Figure Lengend Snippet: SOD2 supplementation alleviates glomerulosclerosis and inhibits the vascular endothelial cells inflammation response. A) Masson's trichrome staining in different groups ( n = 8–9, Scale bar, 50 μm). B, C) Fibrotic area of glomerulus (B) and tubules (C) statistics of Masson's trichrome staining in different groups ( n = 8–9). D) PAS staining in different groups ( n = 8–9, Scale bar, 50 μm). E) Systolic blood pressure in different groups detected by tail-cuff ( n = 8–10). F) ELISA of urinary microalbumin in different groups ( n = 8–10). G) Analysis of Cr in different groups ( n = 8–9). H) Relative fluorescence intensity statistics of IF staining of Fibronectin ( n = 5). I) IF staining of Fibronectin in different groups ( n = 5, Scale bar, 20 μm). J, K) Western blot of Fibronectin in different groups. GAPDH was used as a control ( n = 4). Dot plots represent quantitative densitometric data from Western blot. L) IHC staining of F4/80 in different groups ( n = 5, Scale bar, 50 μm). M) IHC semi-quantitative IOD analysis of F4/80 ( n = 5). N, O) Western blot of CD31, VCAM-1, and ICAM-1 in immortalized HAECs transfected with shRNA of LONP1 and treated with MnTBAP. β-Actin was used as a control ( n = 3). Dot plots represent quantitative densitometric data from Western blot. P, Q) Western blot of CD31, VCAM-1, and ICAM-1 in MAECs transfected with shRNA of LONP1 and treated with MnTBAP. GAPDH was used as a control of CD31, β-Actin was used as a control of VCAM-1 and ICAM-1 ( n = 3). Dot plots represent quantitative densitometric data from Western blot. R, S) The IL-6 (R) and TNF-α (S) levels of cell medium in MAECs transfected with shRNA of LONP1 and treated with MnTBAP were detected by ELISA ( n = 3). T, U) Western blot of CD31, VCAM-1, and ICAM-1 in immortalized HAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid. β-Actin was used as a control ( n = 3). Dot plots represent quantitative densitometric data from Western blot. V, W) Western blot of CD31, VCAM-1, and ICAM-1 in MAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid. GAPDH was used as a control of CD31, β-Actin was used as a control of VCAM-1 and ICAM-1 ( n = 3). Dot plots represent quantitative densitometric data from Western blot. X, Y) The IL-6 (X) and TNF-α (Y) levels of cell medium in MAECs co-transfected with shRNA of LONP1 and SOD2 overexpression plasmid were detected by ELISA ( n = 3). IOD, Integral Optical Density.

    Article Snippet: Cells were treated with 50 μM MnTBAP (MCE, HY-126397) for 12 h and then transfected with shRNA of LONP1 or treated with Ang II.

    Techniques: Staining, Enzyme-linked Immunosorbent Assay, Fluorescence, Western Blot, Control, Immunohistochemistry, Transfection, shRNA, Over Expression, Plasmid Preparation

    Effect of MnTBAP cotreatment on the viability of cisplatin-treated UB/OC-1 cells. A) Dose-dependent cytotoxicity in UB/OC-1 cells after cisplatin treatment. B) Cell viability assay of UB/OC-1 cells after treatment with cisplatin, MnTBAP+Cisplatin, and MnTBAP alone indicates that the cisplatin-mediated cell death was attenuated with MnTBAP cotreatment Results are expressed as mean ± standard deviation, n = 7. ## p < 0.01 vs cisplatin.

    Journal: Toxicology Reports

    Article Title: MnTBAP, a peroxynitrite scavenger, attenuates cisplatin-induced apoptosis and cytotoxicity in organ of Corti cells

    doi: 10.1016/j.toxrep.2025.101967

    Figure Lengend Snippet: Effect of MnTBAP cotreatment on the viability of cisplatin-treated UB/OC-1 cells. A) Dose-dependent cytotoxicity in UB/OC-1 cells after cisplatin treatment. B) Cell viability assay of UB/OC-1 cells after treatment with cisplatin, MnTBAP+Cisplatin, and MnTBAP alone indicates that the cisplatin-mediated cell death was attenuated with MnTBAP cotreatment Results are expressed as mean ± standard deviation, n = 7. ## p < 0.01 vs cisplatin.

    Article Snippet: UB/OC-1 cell lines were plated and treated after 24 hours with 100 μM MnTBAP (ChemCruz, sc-221954A, Santa Cruz, CA), one hour prior to cisplatin treatment.

    Techniques: Viability Assay, Standard Deviation

    Effect of MnTBAP cotreatment on cisplatin-induced nitrative stress. A) Immunocytochemistry analysis with anti-nitrotyrosine was used to assess the nitrative stress in UB/OC-1 cells. Magenta staining indicates immunoreactivity to anti-nitrotyrosine while blue indicates nuclear staining with DAPI. B) Quantification of the immunostaining suggested that the level of 3-NT expression increased significantly with cisplatin treatment which was attenuated by MnTBAP cotreatment. The results are expressed as mean ± standard error, n = 6, ****p < 0.0001 vs control, #### p < 0.0001 vs cisplatin, scale bar = 20 µm.

    Journal: Toxicology Reports

    Article Title: MnTBAP, a peroxynitrite scavenger, attenuates cisplatin-induced apoptosis and cytotoxicity in organ of Corti cells

    doi: 10.1016/j.toxrep.2025.101967

    Figure Lengend Snippet: Effect of MnTBAP cotreatment on cisplatin-induced nitrative stress. A) Immunocytochemistry analysis with anti-nitrotyrosine was used to assess the nitrative stress in UB/OC-1 cells. Magenta staining indicates immunoreactivity to anti-nitrotyrosine while blue indicates nuclear staining with DAPI. B) Quantification of the immunostaining suggested that the level of 3-NT expression increased significantly with cisplatin treatment which was attenuated by MnTBAP cotreatment. The results are expressed as mean ± standard error, n = 6, ****p < 0.0001 vs control, #### p < 0.0001 vs cisplatin, scale bar = 20 µm.

    Article Snippet: UB/OC-1 cell lines were plated and treated after 24 hours with 100 μM MnTBAP (ChemCruz, sc-221954A, Santa Cruz, CA), one hour prior to cisplatin treatment.

    Techniques: Immunocytochemistry, Staining, Immunostaining, Expressing, Control

    Effect of MnTBAP cotreatment on cisplatin-induced changes in the expression levels of apoptotic genes. A) Heat map depicts differentially expressed apoptotic genes in UB/OC-1 cells. The expression levels of genes in each treatment group were normalized with control. B) Cisplatin treatment induced the upregulation of many pro-apoptotic genes, while MnTBAP cotreatment attenuated their expression. MnTBAP cotreatment also upregulated the expression of anti-apoptotic genes. Results expressed as mean ± standard deviation, # p < 0.05, ## p < 0.01, n = 4.

    Journal: Toxicology Reports

    Article Title: MnTBAP, a peroxynitrite scavenger, attenuates cisplatin-induced apoptosis and cytotoxicity in organ of Corti cells

    doi: 10.1016/j.toxrep.2025.101967

    Figure Lengend Snippet: Effect of MnTBAP cotreatment on cisplatin-induced changes in the expression levels of apoptotic genes. A) Heat map depicts differentially expressed apoptotic genes in UB/OC-1 cells. The expression levels of genes in each treatment group were normalized with control. B) Cisplatin treatment induced the upregulation of many pro-apoptotic genes, while MnTBAP cotreatment attenuated their expression. MnTBAP cotreatment also upregulated the expression of anti-apoptotic genes. Results expressed as mean ± standard deviation, # p < 0.05, ## p < 0.01, n = 4.

    Article Snippet: UB/OC-1 cell lines were plated and treated after 24 hours with 100 μM MnTBAP (ChemCruz, sc-221954A, Santa Cruz, CA), one hour prior to cisplatin treatment.

    Techniques: Expressing, Control, Standard Deviation

    Effect of MnTBAP cotreatment on cisplatin-induced changes in the expression levels of activated Caspase-3. A) Immunocytochemistry analysis of UB/OC-1 cell lines with anti-caspase-3 was used to assess apoptosis. Orange staining indicates immunoreactivity to anti-Caspase-3 while blue indicates nuclear staining with DAPI. B) Quantification of the staining intensity suggested that the level of activated Caspase-3 expression increased significantly with cisplatin treatment which was attenuated by MnTBAP cotreatment. The results are expressed as mean ± standard error, n = 6, ****p < 0.0001 vs control, #### p < 0.0001 vs cisplatin, scale bar = 20 µm.

    Journal: Toxicology Reports

    Article Title: MnTBAP, a peroxynitrite scavenger, attenuates cisplatin-induced apoptosis and cytotoxicity in organ of Corti cells

    doi: 10.1016/j.toxrep.2025.101967

    Figure Lengend Snippet: Effect of MnTBAP cotreatment on cisplatin-induced changes in the expression levels of activated Caspase-3. A) Immunocytochemistry analysis of UB/OC-1 cell lines with anti-caspase-3 was used to assess apoptosis. Orange staining indicates immunoreactivity to anti-Caspase-3 while blue indicates nuclear staining with DAPI. B) Quantification of the staining intensity suggested that the level of activated Caspase-3 expression increased significantly with cisplatin treatment which was attenuated by MnTBAP cotreatment. The results are expressed as mean ± standard error, n = 6, ****p < 0.0001 vs control, #### p < 0.0001 vs cisplatin, scale bar = 20 µm.

    Article Snippet: UB/OC-1 cell lines were plated and treated after 24 hours with 100 μM MnTBAP (ChemCruz, sc-221954A, Santa Cruz, CA), one hour prior to cisplatin treatment.

    Techniques: Expressing, Immunocytochemistry, Staining, Control

    Effect of MnTBAP cotreatment on cisplatin-induced decrease in LMO4 levels. A) Immunoblot analysis with anti-LMO4 was used to assess LMO4 protein levels in UB/OC-1 cells. Actin was used for normalization. B) Quantification of the bands indicated that cisplatin treatment reduced LMO4 protein levels, while cotreatment with MnTBAP attenuated the cisplatin-mediated decrease in LMO4 levels. The results are expressed as mean ± standard error, n = 4, **p < 0.01 vs control, #### p < 0.01 vs cisplatin.

    Journal: Toxicology Reports

    Article Title: MnTBAP, a peroxynitrite scavenger, attenuates cisplatin-induced apoptosis and cytotoxicity in organ of Corti cells

    doi: 10.1016/j.toxrep.2025.101967

    Figure Lengend Snippet: Effect of MnTBAP cotreatment on cisplatin-induced decrease in LMO4 levels. A) Immunoblot analysis with anti-LMO4 was used to assess LMO4 protein levels in UB/OC-1 cells. Actin was used for normalization. B) Quantification of the bands indicated that cisplatin treatment reduced LMO4 protein levels, while cotreatment with MnTBAP attenuated the cisplatin-mediated decrease in LMO4 levels. The results are expressed as mean ± standard error, n = 4, **p < 0.01 vs control, #### p < 0.01 vs cisplatin.

    Article Snippet: UB/OC-1 cell lines were plated and treated after 24 hours with 100 μM MnTBAP (ChemCruz, sc-221954A, Santa Cruz, CA), one hour prior to cisplatin treatment.

    Techniques: Western Blot, Control